从精神分裂症患者的真实世界数据中预测阿塞纳的延续
Yoshiteru Takekita1, Shuichi Hiraoka2, Yasuhiro Iwama2
1Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan. takekity@takii.kmu.ac.jp.
Annals of general psychiatry
|August 2, 2024
概括
持续使用阿塞纳 (一种精神分裂症药物) 的预测因素包括更高的原等效剂量和更长的疾病持续时间. 这些因素是阿塞纳的独特特征,强调了个性化精神分裂症治疗计划的必要性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 现实世界的证据.
背景情况:
- 在精神分裂症中,抗精神病药物治疗的延续有显著的差异.
- 患者和药物特异性因素影响治疗坚持.
- 亚塞纳子舌下药片具有独特的配方特性,影响了粘附性.
研究的目的:
- 为了确定与患者相关的药物持续治疗的预测因子,对阿塞纳平子舌药片.
- 分析现实世界的数据,以确定影响阿塞纳坚持的因素.
主要方法:
- 利用了来自日本市场后监测的真实数据 (n=3236).
- 采用多变量逻辑回归来识别延续的预测因素.
- 进行了生存分析,以进一步评估延续趋势.
主要成果:
- 较高的原等效剂量 (>600毫克/天) 和更长的疾病持续时间 (≥25年) 是阿塞纳持续的显著预测因素.
- 总体而言,延续率为40.6%.
- 患有这些因素的患者的持续率更高 (分别为46.3%和47.9%),当两种因素都存在时,52.5%的患者继续治疗.
结论:
- 对阿塞纳持续使用的患者相关预测因子与其他抗精神病药物的预测因子不同.
- 识别特异性预测因素对于有效的精神分裂症管理至关重要.
- 根据已识别的预测因子进行量身定制的治疗干预,可以改善患者的治疗结果.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
01:28Psychosis and Antipsychotic Drugs: Overview
213
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
213
01:28Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
108
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
108
01:29Psychological and Sociocultural Causes of Schizophrenia
81
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
81
01:19Pharmacovigilance
801
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
801